Discovery of GSBR-1290, a Highly Potent, Orally Available, Novel Small Molecule GLP-1 Receptor Agonist

被引：1
|
作者：
Mao, Ting
Meng, Qinghua
Zhang, Haizhen
Zhang, Jinqiang J.
Shi, Songting
Guan, Zhibo
Jiang, Xinglong
Zhang, Fang
Lei, Hui
Lin, Xichen
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-760-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
760-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] An Efficient Cell Model for Screening Small Molecule Agonists of GLP-1 Receptor
    Pi, Ni
    Cheng, Xiyao
    Huang, Yongqi
    Su, Zhengding
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 416A - 416A
  • [42] Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist
    Kawai, Takahiro
    Sun, Bingfa
    Yoshino, Hitoshi
    Feng, Dan
    Suzuki, Yoshiyuki
    Fukazawa, Masanori
    Nagao, Shunsuke
    Wainscott, David B.
    Showalter, Aaron D.
    Droz, Brian A.
    Kobilka, Tong Sun
    Coghlan, Matthew P.
    Willard, Francis S.
    Kawabe, Yoshiki
    Kobilka, Brian K.
    Sloop, Kyle W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (47) : 29959 - 29967
  • [43] Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Agonist, GLP-1-IgG2σ-Fc
    Yang, Yi
    Chen, Fang
    Wan, Deyou
    Liu, Yunhui
    Yang, Li
    Feng, Hongru
    Cui, Xinling
    Gao, Xin
    Song, Haifeng
    PLOS ONE, 2016, 11 (05):
  • [44] Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of and Diabetes
    Palani, Anandan
    Nawrocki, Andrea R.
    Orvieto, Federica
    Bianchi, Elisabetta
    Mandic, Emanuela
    Pessi, Antonello
    Huang, Chunhui
    Deng, Qiaolin
    Toussaint, Nathalie
    Walsh, Erika
    Reddy, Vijay
    Ashley, Eric
    He, Huaibing
    Mumick, Sheena
    Hawes, Brian
    Marsh, Donald
    Erion, Mark
    Nargund, Ravi
    Carrington, Paul E.
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (08): : 1248 - 1254
  • [45] The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying
    Urva, Shweta
    O'Farrell, Libbey
    Du, Yu
    Loh, Mei Teng
    Hemmingway, Andrea
    Qu, Hongchang
    Alsina-Fernandez, Jorge
    Haupt, Axel
    Milicevic, Zvonko
    Coskun, Tamer
    DIABETES OBESITY & METABOLISM, 2023, 25 (09): : 2784 - 2788
  • [46] Novel Use of GLP-1 Receptor Agonist Therapy in HNF4A-MODY
    Broome, David T.
    Tekin, Zehra
    Pantalone, Kevin M.
    Mehta, Adi E.
    DIABETES CARE, 2020, 43 (06) : E65 - E65
  • [47] Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus
    Christensen, Mikkel
    Knop, Filip K.
    Holst, Jens J.
    Vilsboll, Tina
    IDRUGS, 2009, 12 (08) : 503 - 513
  • [48] Exenatide: a GLP-1 receptor agonist as novel therapy for Type 2 diabetes mellitus
    Briones, Mariele
    Bajaj, Mandeep
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (08) : 1055 - 1064
  • [49] Design of a novel long-acting dual GLP-1/GIP receptor agonist
    Dong, Yuanzhen
    Zhang, Jinhua
    Xu, Hongjiang
    Shen, Hengqiao
    Lu, Qin
    Feng, Jun
    Cai, Zhengyan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 100
  • [50] Next Chapter for Weight Control - Small-Molecule GLP-1 Receptor Agonists?
    Abel, E. Dale
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (10): : 949 - 950
12345